SCOT-t, or Succinyl-CoA:3-Ketoacid CoA Transferase, is a protein encoded by the OXCT1 gene in humans. This mitochondrial enzyme is a key player in the ketogenic pathway, specifically in the metabolism of ketone bodies.Ketone bodies, such as acetoacetate and beta-hydroxybutyrate, are produced primarily in the liver and are crucial energy sources during periods of fasting or intensive exercise when glucose availability is low. They are transported to other tissues, like the brain and heart, where they are converted back into acetyl-CoA to enter the citric acid cycle for energy production.
SCOT-t catalyzes the transfer of a CoA group from succinyl-CoA to acetoacetate, producing acetoacetyl-CoA. This step is crucial for the utilization of ketone bodies.Mutations in the OXCT1 gene can lead to SCOT deficiency, also known as Succinyl-CoA:3-Ketoacid CoA Transferase deficiency. This rare metabolic disorder blocks the body from effectively using ketone bodies for energy, leading to ketoacidosis. Indicators often manifest in infancy and include difficulty feeding, vomiting, lethargy, and developmental delay.Understanding the function of SCOT-t provides important insights into energy metabolism, particularly under conditions of glucose deprivation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
L-Carnitine facilitates the transport of fatty acids into mitochondria for β-oxidation, possibly influencing SCOT-t. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, can influence metabolism and may indirectly affect SCOT-t activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, which influences glucose and lipid metabolism, might have an indirect effect on SCOT-t activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activators of AMPK can influence metabolic pathways, potentially impacting SCOT-t activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPAR agonists modulate lipid metabolism and may indirectly affect SCOT-t activity. | ||||||